CTEC · Pharma and healthcare · one day
Convatec (CTEC): news on Saturday 21 November 2026
News from the 24 hours to Saturday morning, 21 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centres on Convatec's trading update, with an upgraded guidance outlook and quicker growth in infusion care. Commentary leans positive as a result.
What drove it
- guidance upgrade
- trading statement
- infusion care growth
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Tue 17 Nov | +5.0 | 2 |
| Wed 18 Nov | +4.7 | 2 |
| Thu 19 Nov | +10.0 | 4 |
| Fri 20 Nov | 0.0 | 1 |
| Sat 21 Nov | +8.7 | 3 |
2 stories · 3 headlines · strongest first
Pharma and healthcare on 21 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Convatec lifts its revenue growth outlook for 2026 to 6.25%–7% +9.32 headlines today · 6 in all, since 19 November · Pieces cover Convatec's guidance upgrade and trading statement call. | ||
| +10.0 | Raised outlook and faster growth in infusion business favour the company. | |
| +1.7 | Slideshow from the company's trading update call; factual coverage, mildly positive context.} | |
| Convatec delivery commentary +5.01 headline today · 2 in all, since 18 November · A piece notes a change in London mood on Convatec. | ||
| +5.8 | Commentary suggests the market backdrop around the shares has turned more favourable. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Convatec: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.